Photobiomodulation: A Promising Safe Therapy for Alzheimer's Disease

PBM therapy shows considerable promise as a safe, non-invasive treatment for AD. However, its widespread clinical application depends on rigorous validation of efficacy through high-quality studies and the development of standardized treatment protocols. The next phase of research will be instrumental in determining whether PBM can transition from an experimental approach to a mainstream therapeutic option for AD. Ongoing and forthcoming clinical studies are expected to contribute to this body of evidence.